Registry of Treatments and Outcomes in Austrian Patients With Localized Rectal Cancer
Collects routine-care treatment information from adults with rectal cancer that has not spread.
Plain-language title generated from the registry record
Registry title: ABCSG R07 Rectal Cancer Registry
Key facts
- Where
- Graz, Innsbruck, Linz, Salzburg, and Wiener Neustadt, AustriaSee the 6 sites
Where in Austria
- Med. University Graz, OncologyGraz, AustriaNot yet recruiting
- Medical University Innsbruck, Internal Medicine VInnsbruck, AustriaNot yet recruiting
- Kepler Universitätsklinikum LinzLinz, AustriaTaking people
- Ordensklinikum Linz - BHSLinz, AustriaNot yet recruiting
- LKH Salzburg-PMU, Univ. Klinik f. Innere Med IIISalzburg, AustriaTaking people
- Universitätsklinikum Wiener Neustadt, Abteilung für Innere Medizin, Hämatologie und int. OnkologieWiener Neustadt, AustriaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Austrian Breast & Colorectal Cancer Study Group
- Trial code
- NCT07780305
- Record updated
- 30 October 2026
- Original description
In Austria, patients with rectal cancer that has not spread to other parts of the body are typically treated with either total neoadjuvant therapy (TNT) or immunotherapy, depending on their microsatellite status (DNA repair capacity).Read full original descriptionShow less
ABCSG R07 Rectal Cancer Registry (RCR) - Multicenter Retrospective and Prospective Analysis of Patients With Localized, Non-metastatic Rectal Cancer in Austria
In Austria, patients with rectal cancer that has not spread to other parts of the body are typically treated with either total neoadjuvant therapy (TNT) or immunotherapy, depending on their microsatellite status (DNA repair capacity).
However, treatment can vary considerably between hospitals in Austria. These differences may include the type and duration of treatment, as well as the active ingredients used. There are currently no clear recommendations on which exact treatment is best for each specific case.
The aim of this observational study is to collect information on the different treatments used in Austria for patients with localized rectal cancer and to document the outcomes of these treatments.
Only information and samples collected as part of the patients' routine care will be used for the study. Participation in the study will not change or affect the treatment chosen by the treating physician.
Inclusion: Female and male participants with age >= 18 years; Signed informed consent obtained prior to registration of the participant; Localized rectal cancer treated with TNT or localized, non-metastatic dMMR/MSI-H rectal cancer, irrespective of treatment.
Exclusion: Distant metastases at primary diagnosis.